From the current studies, we investigate the wide inhibitory anti-emetic profile of a relatively new NK1 receptor antagonist, netupitant, by yourself or together With all the long performing 5-HT3 receptor antagonist, palonosetron, for a potential to scale back emesis in ferrets and shrews. Publishing on IntechOpen permits authors to gain https://randallh641bby8.sunderwiki.com/user